Cerity Partners
NURO

Cerity Partners’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Cerity Partners’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30,000
Closed -$108K – 2370
2023
Q4 		$108K Buy
+30,000
New +$126K ﹤0.01% 1781

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
ACM
Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Cerity Partners's NURO Position: Q1 2024 in Review

Cerity Partners sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2024, closing a stake of 30,000 shares — an estimated $108K sold.

Cerity Partners first reported a position in NURO in Q4 2023 and held it in 1 quarter. The position peaked at $108K in Q4 2023. 12 funds tracked by Wall St. Rank hold NURO as of Q1 2024.

  • Cerity Partners reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cerity Partners sold 30,000 NeuroMetrix, Inc. Common Stock shares in Q1 2024, an estimated $108K.
  • Cerity Partners first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Cerity Partners's NeuroMetrix, Inc. Common Stock position peaked at $108K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2024.

Based on Cerity Partners's 13F filing for Q1 2024, filed 14 May 2024.